ArticleFrontiers in oncology2023
Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma.
Aleksandra Wieczorek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it